Product Overview

Currently there is no treatment for Parkinson’s Disease, only drugs that address symptoms. We aim to gain a better understanding of the disease biology to alter the relentless progression of disability. By assembling a clinical omics dataset of several thousand participants, which includes Whole Genome Sequence (WGS), multi-omic and detailed, longitudinal clinical data, our goal is to discover low frequency, high impact genetic variant that may reveal druggable pathways for treatment or prevention of progression.

genuity-blurred

 

To learn more, download the datasheet below: